AMGN news

Latest 20 stories · newest Nov 5, 2026

AMGN
Amgen Announces Results From Large Real-World Study Showing Treatment With Repatha Reduced Risk Of Fatal Or Nonfatal Heart Attacks By 20% Compared With Ezetimibe In People With ASCVD And Prior Statin Use
News Nov 5, 2026 sentiment +0.60 Source: benzinga.com ↗
AMGN
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $435
Analyst Ratings Nov 5, 2026 sentiment +0.30 Source: benzinga.com ↗
AMGN
Leerink Partners Maintains Market Perform on Amgen, Raises Price Target to $464
Analyst Ratings Nov 5, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $465
Analyst Ratings Nov 4, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
Amgen shares are trading higher after the company reported better-than-expected Q3 financial results and raised its F26 guidance.
WIIM Nov 4, 2026 sentiment +0.80 Source: benzinga.com ↗
AMGN
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Trading Ideas Nov 4, 2026 sentiment 0.00 Source: benzinga.com ↗
AMGN
Wells Fargo Maintains Equal-Weight on Amgen, Raises Price Target to $460
Analyst Ratings Nov 4, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
Truist Securities Maintains Hold on Amgen, Raises Price Target to $398
Analyst Ratings Nov 4, 2026 sentiment +0.10 Source: benzinga.com ↗
AMGN
RBC Capital Maintains Outperform on Amgen, Raises Price Target to $470
Analyst Ratings Nov 4, 2026 sentiment +0.30 Source: benzinga.com ↗
AMGN
Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $410
Analyst Ratings Nov 4, 2026 sentiment +0.30 Source: benzinga.com ↗
AMGN
Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data
Trading Ideas Nov 4, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
Goldman Sachs Maintains Buy on Amgen, Raises Price Target to $536
Analyst Ratings Nov 4, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
TD Cowen Maintains Buy on Amgen, Raises Price Target to $531
Analyst Ratings Nov 4, 2026 sentiment +0.30 Source: benzinga.com ↗
AMGN
JP Morgan Maintains Neutral on Amgen, Raises Price Target to $425
Analyst Ratings Nov 4, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
Citigroup Maintains Neutral on Amgen, Raises Price Target to $465
Analyst Ratings Nov 4, 2026 sentiment +0.20 Source: benzinga.com ↗
AMGN
Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $530
Analyst Ratings Nov 4, 2026 sentiment +0.30 Source: benzinga.com ↗
AMGN
UBS Maintains Buy on Amgen, Raises Price Target to $530
Analyst Ratings Nov 4, 2026 sentiment +0.30 Source: benzinga.com ↗
AMGN
Canaccord Genuity Maintains Hold on Amgen, Raises Price Target to $440
Analyst Ratings Nov 4, 2026 sentiment +0.10 Source: benzinga.com ↗
AMGN
Amgen Raises FY2026 GAAP EPS Guidance from $15.80-$17.08 to $18.34-$19.28 vs $15.90 Est
News Nov 3, 2026 sentiment +0.60 Source: benzinga.com ↗
AMGN
Amgen Q3 Adj. EPS $6.45 Beats $5.79 Estimate, Sales $10.365B Beat $10.071B Estimate
News Nov 3, 2026 sentiment +0.70 Source: benzinga.com ↗
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same AMGN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/AMGN/newsSTART FREE